Indee Labs Revenue and Competitors
Estimated Revenue & Valuation
- Indee Labs's estimated annual revenue is currently $697.5k per year.
- Indee Labs's estimated revenue per employee is $77,500
Employee Data
- Indee Labs has 9 Employees.
- Indee Labs grew their employee count by 29% last year.
Indee Labs's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
Indee Labs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Indee Labs?
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies. Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
keywords:N/AN/A
Total Funding
9
Number of Employees
$697.5k
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | 0% | N/A |
#2 | $0.9M | 9 | -10% | N/A |
#3 | $0.1M | 9 | -18% | N/A |
#4 | $0.9M | 9 | 13% | N/A |
#5 | $1.4M | 9 | 0% | N/A |